According to brand-new research from the University of Southampton.

GEN publishes a print edition 21 times a yr and has additional exclusive editorial content online, like news and analysis and also blogs, podcasts, webinars, polls, videos, and application notes. GEN’s unique information and technology concentrate includes the complete bioproduct life routine from early-stage R&D, to applied study including omics, biomarkers, in addition to diagnostics, to commercialization and bioprocessing.. ART eligibility shorter for male HIV individuals in rural South Africa Male HIV patients in rural Southern Africa reach the low immunity levels necessary to become qualified to receive antiretroviral treatment in less than half the period it requires for immunity levels to drop to comparable levels in women, according to brand-new research from the University of Southampton., a technology-based developer and producer of innovative technologies and products, today announced results for its first quarter ended June 30, 2016 of Fiscal Year 2016. Revenues for the 90 days ended June 30, 2015 were $1,055,928 when compared with $623,674 for the three months ended June 30, 2014, a rise of 69 percent. Net income for the first one fourth was $434,548 or $0.01 per share when compared with $35,828 for the same period this past year, an increase of just one 1,113 percent.